Home Other Building Blocks 77337-73-6
77337-73-6,MFCD00886588
Catalog No.:AA003NJ9

77337-73-6 | Acamprosate Calcium

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
97%
in stock  
$8.00   $6.00
- +
10mg
97%
in stock  
$29.00   $21.00
- +
50mg
97%
in stock  
$50.00   $35.00
- +
100mg
≥98%
in stock  
$63.00   $44.00
- +
1g
>98.0%(HPLC)
in stock  
$69.00   $48.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Literature
Technical Information
Catalog Number:
AA003NJ9
Chemical Name:
Acamprosate Calcium
CAS Number:
77337-73-6
Molecular Formula:
C10H20CaN2O8S2
Molecular Weight:
400.4824
MDL Number:
MFCD00886588
SMILES:
CC(=O)NCCCS(=O)(=O)[O-].CC(=O)NCCCS(=O)(=O)[O-].[Ca+2]
NSC Number:
759186
Properties
Properties
 
Form:
Solid  
MP:
>297ºC (dec.)  
Storage:
Inert atmosphere;Room Temperature;  

Computed Properties
 
Complexity:
202  
Covalently-Bonded Unit Count:
3  
Heavy Atom Count:
23  
Hydrogen Bond Acceptor Count:
8  
Hydrogen Bond Donor Count:
2  
Rotatable Bond Count:
6  

Literature

Title: Impact of acamprosate on behavior and brain-derived neurotrophic factor: an open-label study in youth with fragile X syndrome.

Journal: Psychopharmacology 20130701

Title: New pharmacological treatment strategies for relapse prevention.

Journal: Current topics in behavioral neurosciences 20130101

Title: Cigarette smoking predicts differential benefit from naltrexone for alcohol dependence.

Journal: Biological psychiatry 20121115

Title: Cocaine reverses the naltrexone-induced reduction in operant ethanol self-administration: the effects on immediate-early gene expression in the rat prefrontal cortex.

Journal: Neuropharmacology 20121101

Title: Involvement of mGlu5 and NMDA receptors in the antidepressant-like effect of acamprosate in the tail suspension test.

Journal: Progress in neuro-psychopharmacology & biological psychiatry 20121001

Title: The impact of acamprosate on cue reactivity in alcohol dependent individuals: a functional magnetic resonance imaging study.

Journal: Journal of clinical psychopharmacology 20121001

Title: The glycine reuptake inhibitor Org24598 and acamprosate reduce ethanol intake in the rat; tolerance development to acamprosate but not to Org24598.

Journal: Addiction biology 20120901

Title: The cost-effectiveness of tailored, postal feedback on general practitioners' prescribing of pharmacotherapies for alcohol dependence.

Journal: Drug and alcohol dependence 20120801

Title: Trajectory analyses in alcohol treatment research.

Journal: Alcoholism, clinical and experimental research 20120801

Title: Does session attendance by a supportive significant other predict outcomes in individual treatment for alcohol use disorders?

Journal: Alcoholism, clinical and experimental research 20120701

Title: Pharmacotherapy for adolescent alcohol use disorder.

Journal: CNS drugs 20120701

Title: Ethanol withdrawal-induced brain metabolites and the pharmacological effects of acamprosate in mice lacking ENT1.

Journal: Neuropharmacology 20120601

Title: Strategies for evaluating the economic value of drugs in alcohol dependence treatment.

Journal: Drug and alcohol dependence 20120501

Title: Influence of ionization source design on matrix effects during LC-ESI-MS/MS analysis.

Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20120415

Title: Acamprosate for alcohol dependence: a sex-specific meta-analysis based on individual patient data.

Journal: Alcoholism, clinical and experimental research 20120301

Title: Baseline trajectories of heavy drinking and their effects on postrandomization drinking in the COMBINE Study: empirically derived predictors of drinking outcomes during treatment.

Journal: Alcohol (Fayetteville, N.Y.) 20120301

Title: Impact of depressive symptoms on future alcohol use in patients with co-occurring bipolar disorder and alcohol dependence: a prospective analysis in an 8-week randomized controlled trial of acamprosate.

Journal: Alcoholism, clinical and experimental research 20120301

Title: Acamprosate modulates experimental autoimmune encephalomyelitis.

Journal: Inflammopharmacology 20120201

Title: A randomized, double-blind, placebo-controlled clinical trial of acamprosate in alcohol-dependent individuals with bipolar disorder: a preliminary report.

Journal: Bipolar disorders 20120201

Title: Sleep disturbance in alcoholism: proposal of a simple measurement, and results from a 24-week randomized controlled study of alcohol-dependent patients assessing acamprosate efficacy.

Journal: Alcohol and alcoholism (Oxford, Oxfordshire) 20120101

Title: Pharmacogenetics of alcoholism: a clinical neuroscience perspective.

Journal: Pharmacogenomics 20120101

Title: An open-label naturalistic pilot study of acamprosate in youth with autistic disorder.

Journal: Journal of child and adolescent psychopharmacology 20111201

Title: [Meta-analysis of pharmacological therapy with acamprosate, naltrexone, and disulfiram--a systematic review].

Journal: Ugeskrift for laeger 20111128

Title: The effects of combined acamprosate and integrative behaviour therapy in the outpatient treatment of alcohol dependence: a randomized controlled trial.

Journal: Drug and alcohol dependence 20111101

Title: Opioid antagonists for the treatment of alcohol dependence.

Journal: American family physician 20111101

Title: An open-label trial of acamprosate in the treatment of pathological gambling.

Journal: Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20111101

Title: Involvement of the atrial natriuretic peptide transcription factor GATA4 in alcohol dependence, relapse risk and treatment response to acamprosate.

Journal: The pharmacogenomics journal 20111001

Title: A LC-MS analysis of acamprosate from human plasma: pharmacokinetic application.

Journal: Drug testing and analysis 20111001

Title: Acamprosate-responsive brain sites for suppression of ethanol intake and preference.

Journal: American journal of physiology. Regulatory, integrative and comparative physiology 20111001

Title: Circadian and acamprosate modulation of elevated ethanol drinking in mPer2 clock gene mutant mice.

Journal: Chronobiology international 20111001

Title: [Good effect of drug therapy against alcoholism].

Journal: Lakartidningen 20111001

Title: Comorbid anxiety disorders and baseline medication regimens predict clinical outcomes in individuals with co-occurring bipolar disorder and alcohol dependence: Results of a randomized controlled trial.

Journal: Psychiatry research 20110815

Title: A literature review of cost-benefit analyses for the treatment of alcohol dependence.

Journal: International journal of environmental research and public health 20110801

Title: Effects of acamprosate on cognition in a treatment study of patients with schizophrenia spectrum disorders and comorbid alcohol dependence.

Journal: The Journal of nervous and mental disease 20110701

Title: How cognitive assessment through clinical neurophysiology may help optimize chronic alcoholism treatment.

Journal: Neurophysiologie clinique = Clinical neurophysiology 20110701

Title: Using medication-assisted treatment for substance use disorders: evidence of barriers and facilitators of implementation.

Journal: Addictive behaviors 20110601

Title: Self-efficacy change as a mediator of associations between therapeutic bond and one-year outcomes in treatments for alcohol dependence.

Journal: Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors 20110601

Title: Acamprosate attenuates cue-induced reinstatement of nicotine-seeking behavior in rats.

Journal: Behavioural pharmacology 20110601

Title: Alcohol dependence treatments: comprehensive healthcare costs, utilization outcomes, and pharmacotherapy persistence.

Journal: The American journal of managed care 20110601

Title: Pharmacologically induced alcohol craving in treatment seeking alcoholics correlates with alcoholism severity, but is insensitive to acamprosate.

Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20110501

Title: Marked reduction of heavy drinking did not reduce nicotine use over 1 year in a clinical sample of alcohol-dependent patients.

Journal: Pharmacopsychiatry 20110501

Title: A double-blind, placebo-controlled pilot trial of acamprosate for the treatment of cocaine dependence.

Journal: Addictive behaviors 20110301

Title: Baseline trajectories of drinking moderate acamprosate and naltrexone effects in the COMBINE study.

Journal: Alcoholism, clinical and experimental research 20110301

Title: Addiction treatment: level of care determination.

Journal: Primary care 20110301

Title: Effectiveness of acamprosate in the treatment of alcohol dependence.

Journal: American family physician 20110301

Title: Acamprosate reduces ethanol drinking behaviors and alters the metabolite profile in mice lacking ENT1.

Journal: Neuroscience letters 20110225

Title: Moderating effects of a craving intervention on the relation between negative mood and heavy drinking following treatment for alcohol dependence.

Journal: Journal of consulting and clinical psychology 20110201

Title: Acamprosate in the treatment of binge eating disorder: a placebo-controlled trial.

Journal: The International journal of eating disorders 20110101

Title: Alcohol-use disorders and depression: results from individual patient data meta-analysis of the acamprosate-controlled studies.

Journal: Alcohol and alcoholism (Oxford, Oxfordshire) 20110101

Title: Alcohol dependence: analysis of factors associated with retention of patients in outpatient treatment.

Journal: Alcohol and alcoholism (Oxford, Oxfordshire) 20110101

Title: Does family history of alcoholism moderate naltrexone's effects on alcohol use?

Journal: Journal of studies on alcohol and drugs 20110101

Title: Urinary ethyl glucuronide and ethyl sulfate testing for recent drinking in alcohol-dependent outpatients treated with acamprosate or placebo.

Journal: Alcohol and alcoholism (Oxford, Oxfordshire) 20110101

Title: Pharmacological treatment of insomnia in alcohol recovery: a systematic review.

Journal: Alcohol and alcoholism (Oxford, Oxfordshire) 20110101

Title: Medical treatment of alcohol dependence: a systematic review.

Journal: International journal of psychiatry in medicine 20110101

Title: [Cochrane review about the effect of acamprosate].

Journal: Ugeskrift for laeger 20101206

Title: Percentage of subjects with no heavy drinking days: evaluation as an efficacy endpoint for alcohol clinical trials.

Journal: Alcoholism, clinical and experimental research 20101201

Title: Acamprosate calcium as augmentation therapy for anxiety disorders.

Journal: The Annals of pharmacotherapy 20101201

Title: Brief report: acamprosate in fragile X syndrome.

Journal: Journal of autism and developmental disorders 20101101

Title: Network support as a prognostic indicator of drinking outcomes: the COMBINE Study.

Journal: Journal of studies on alcohol and drugs 20101101

Title: Glycine transporter-1 blockade leads to persistently reduced relapse-like alcohol drinking in rats.

Journal: Biological psychiatry 20101015

Title: Effect of acamprosate on magnetic resonance spectroscopy measures of central glutamate in detoxified alcohol-dependent individuals: a randomized controlled experimental medicine study.

Journal: Archives of general psychiatry 20101004

Title: Effect of early and late compliance on the effectiveness of acamprosate in the treatment of alcohol dependence.

Journal: Journal of substance abuse treatment 20101001

Title: Gender differences in alcohol treatment: an analysis of outcome from the COMBINE study.

Journal: Alcoholism, clinical and experimental research 20101001

Title: Acamprosate for alcohol dependence.

Journal: The Cochrane database of systematic reviews 20100908

Title: Acamprosate modulates alcohol-induced hippocampal NMDA receptors and brain microsomal Ca2+-ATPase but induces oxidative stress in rat.

Journal: The Journal of membrane biology 20100901

Title: Gambling on acamprosate: a case report.

Journal: The Journal of clinical psychiatry 20100901

Title: Acamprosate determinations in plasma and cerebrospinal fluid after multiple dosing measured by liquid chromatography-mass spectroscopy: a pharmacokinetic study in healthy volunteers.

Journal: Therapeutic drug monitoring 20100801

Title: The effect of alcohol treatment on social costs of alcohol dependence: results from the COMBINE study.

Journal: Medical care 20100501

Title: The adoption of alcohol pharmacotherapies in the Clinical Trials Network: the influence of research network participation.

Journal: Journal of substance abuse treatment 20100401

Title: Revisiting the cost-effectiveness of the COMBINE study for alcohol dependent patients: the patient perspective.

Journal: Medical care 20100401

Title: Pharmacotherapy of alcohol use disorders in the Veterans Health Administration.

Journal: Psychiatric services (Washington, D.C.) 20100401

Title: Naltrexone and combined behavioral intervention effects on trajectories of drinking in the COMBINE study.

Journal: Drug and alcohol dependence 20100301

Title: Acamprosate.

Journal: Expert opinion on drug metabolism & toxicology 20100301

Title: Acamprosate: a prototypic neuromodulator in the treatment of alcohol dependence.

Journal: CNS & neurological disorders drug targets 20100301

Title: Pharmacotherapies for alcoholism: the old and the new.

Journal: CNS & neurological disorders drug targets 20100301

Title: Glycine receptors in the nucleus accumbens involved in the ethanol intake-reducing effect of acamprosate.

Journal: Alcoholism, clinical and experimental research 20100101

Title: Glycine receptors involved in acamprosate's modulation of accumbal dopamine levels: an in vivo microdialysis study.

Journal: Alcoholism, clinical and experimental research 20100101

Title: The neurobiology, clinical efficacy and safety of acamprosate in the treatment of alcohol dependence.

Journal: Expert opinion on drug safety 20100101

Title: The effects of current subsyndromal psychiatric symptoms or past psychopathology on alcohol dependence treatment outcomes and acamprosate efficacy.

Journal: The American journal on addictions 20100101

Title: Why is disulfiram superior to acamprosate in the routine clinical setting? A retrospective long-term study in 353 alcohol-dependent patients.

Journal: Alcohol and alcoholism (Oxford, Oxfordshire) 20100101

Title: Acamprosate: how, where, and for whom does it work? Mechanism of action, treatment targets, and individualized therapy.

Journal: Current pharmaceutical design 20100101

Title: [Impact of functional social support for abstinence after inpatient detoxification].

Journal: Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater 20100101

Title: Retrospective review of acute acamprosate exposures to a poison control system.

Journal: The American journal on addictions 20100101

Title: Clinical predictors of outcome from an Australian pharmacological relapse prevention trial.

Journal: Alcohol and alcoholism (Oxford, Oxfordshire) 20100101

Title: Comparison of healthcare utilization among patients treated with alcoholism medications.

Journal: The American journal of managed care 20100101

Title: The effect of acamprosate on alcohol craving and correlation with hypothalamic pituitary adrenal (HPA) axis hormones and beta-endorphin.

Journal: Brain research 20091211

Title: Naltrexone for the treatment of alcohol dependence among African Americans: results from the COMBINE Study.

Journal: Drug and alcohol dependence 20091201

Title: Alcohol dependence: after the withdrawal phase. Long-term abstinence: better health and psychosocial status. Psychosocial support for a chronic disorder. Some drugs are useful adjuncts to medical support.

Journal: Prescrire international 20091001

Title: Blood glucose level, alcohol heavy drinking, and alcohol craving during treatment for alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) Study.

Journal: Alcoholism, clinical and experimental research 20090901

Title: Cue-induced alcohol-seeking behaviour is reduced by disrupting the reconsolidation of alcohol-related memories.

Journal: Psychopharmacology 20090801

Title: The effects of acamprosate on alcohol-cue reactivity and alcohol priming in dependent patients: a randomized controlled trial.

Journal: Psychopharmacology 20090701

Title: Predicting the effect of naltrexone and acamprosate in alcohol-dependent patients using genetic indicators.

Journal: Addiction biology 20090701

Title: [Interaction between Saint Johns Wort and alcohol deterrents?].

Journal: Lakartidningen 20090701

Title: Acamprosate and naltrexone treatment effects on ethanol and sucrose seeking and intake in ethanol-dependent and nondependent rats.

Journal: Psychopharmacology 20090601

Title: Treatment of alcohol dependence.

Journal: The Ceylon medical journal 20090601

Title: The implications of medication development in the treatment of substance use disorders in developing countries.

Journal: Current opinion in psychiatry 20090501

Title: Searching for responders to acamprosate and naltrexone in alcoholism treatment: rationale and design of the PREDICT study.

Journal: Alcoholism, clinical and experimental research 20090401

Title: Alcohol and opioid dependence medications: prescription trends, overall and by physician specialty.

Journal: Drug and alcohol dependence 20090101

Title: The state of pharmacotherapy for the treatment of alcohol dependence.

Journal: Journal of substance abuse treatment 20090101

Title: Expectancy in double-blind placebo-controlled trials: an example from alcohol dependence.

Journal: Psychotherapy and psychosomatics 20090101

Title: Initiating acamprosate within-detoxification versus post-detoxification in the treatment of alcohol dependence.

Journal: Addictive behaviors 20090101

Title: Pharmacokinetics of acamprosate calcium in healthy Chinese subjects after oral administration of three dosage levels.

Journal: Arzneimittel-Forschung 20090101

Title: Successful acamprosate treatment of alcohol dependence in schizophrenia.

Journal: Schizophrenia research 20081201

Title: The influence of various glutamate receptors antagonists on anxiety-like effect of ethanol withdrawal in a plus-maze test in rats.

Journal: European journal of pharmacology 20081119

Title: Glutamatergic dysfunction in schizophrenia: from basic neuroscience to clinical psychopharmacology.

Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20081101

Title: Acute effects of acamprosate and MPEP on ethanol Drinking-in-the-Dark in male C57BL/6J mice.

Journal: Alcoholism, clinical and experimental research 20081101

Title: Do patients with alcohol dependence respond to placebo? Results from the COMBINE Study.

Journal: Journal of studies on alcohol and drugs 20081101

Title: Opioid antagonists for pharmacological treatment of alcohol dependence - a critical review.

Journal: Current drug abuse reviews 20081101

Title: Effects of naltrexone and acamprosate on alcohol-induced NGFI-A expression in mouse brain.

Journal: Neurochemical research 20081001

Title: Intermittent access to 20% ethanol induces high ethanol consumption in Long-Evans and Wistar rats.

Journal: Alcoholism, clinical and experimental research 20081001

Title: Preserved DNA from past clinical trials yields new information about a subtype of alcoholism.

Journal: Current psychiatry reports 20081001

Title: Cost and cost-effectiveness of the COMBINE study in alcohol-dependent patients.

Journal: Archives of general psychiatry 20081001

Title: Acamprosate attenuates the handling induced convulsions during alcohol withdrawal in Swiss Webster mice.

Journal: Physiology & behavior 20080903

Title: Metabotropic glutamate receptor 5 (mGluR5) regulation of ethanol sedation, dependence and consumption: relationship to acamprosate actions.

Journal: The international journal of neuropsychopharmacology 20080901

Title: Relationship between medication adherence and treatment outcomes: the COMBINE study.

Journal: Alcoholism, clinical and experimental research 20080901

Title: An intervention for treating alcohol dependence: relating elements of Medical Management to patient outcomes with implications for primary care.

Journal: Annals of family medicine 20080901

Title: Aminomethylpiperazines as selective urotensin antagonists.

Journal: Bioorganic & medicinal chemistry letters 20080815

Title: Analysis of acamprosate in beagle dog plasma by LC-MS-MS.

Journal: Archives of pharmacal research 20080801

Title: Acamprosate: recent findings and future research directions.

Journal: Alcoholism, clinical and experimental research 20080701

Title: Do acamprosate or naltrexone have an effect on daily drinking by reducing craving for alcohol?

Journal: Addiction (Abingdon, England) 20080601

Title: Investigation of the relationship between in vitro and in vivo release behaviors of acamprosate from enteric-coated tablets.

Journal: Archives of pharmacal research 20080601

Title: [Pharmacotherapy of alcohol dependence].

Journal: MMW Fortschritte der Medizin 20080519

Title: [Alcohol dependence: diagnosis and treatment].

Journal: La Revue de medecine interne 20080401

Title: Cloninger's typology and treatment outcome in alcohol-dependent subjects during pharmacotherapy with naltrexone.

Journal: Addiction biology 20080301

Title: The effect of acamprosate on alcohol and food craving in patients with alcohol dependence.

Journal: Drug and alcohol dependence 20080301

Title: A microdialysis study of extracellular levels of acamprosate and naltrexone in the rat brain following acute and repeated administration.

Journal: Addiction biology 20080301

Title: Effect of chronic acamprosate treatment on voluntary alcohol intake and beta-endorphin plasma levels in rats selectively bred for high alcohol preference.

Journal: Neuroscience letters 20080206

Title: Effects of acamprosate on neuronal receptors and ion channels expressed in Xenopus oocytes.

Journal: Alcoholism, clinical and experimental research 20080201

Title: An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study.

Journal: Archives of general psychiatry 20080201

Title: From the neurobiologic basis of alcohol dependency to pharmacologic treatment strategies: bridging the knowledge gap.

Journal: Southern medical journal 20080201

Title: Substance abuse and schizophrenia: pharmacotherapeutic intervention.

Journal: Journal of substance abuse treatment 20080101

Title: Update on neuropharmacological treatments for alcoholism: scientific basis and clinical findings.

Journal: Biochemical pharmacology 20080101

Title: A randomized, multicentre, open-label, comparative trial of disulfiram, naltrexone and acamprosate in the treatment of alcohol dependence.

Journal: Alcohol and alcoholism (Oxford, Oxfordshire) 20080101

Title: NMDA receptor blockade: a novel avenue for tobacco intervention?

Journal: Medical hypotheses 20080101

Title: Combined pharmacotherapies and behavioral interventions for alcohol dependence (The COMBINE Study): examination of posttreatment drinking outcomes.

Journal: Journal of studies on alcohol and drugs 20080101

Title: Acamprosate supports abstinence, naltrexone prevents excessive drinking: evidence from a meta-analysis with unreported outcomes.

Journal: Journal of psychopharmacology (Oxford, England) 20080101

Title: Acamprosate efficacy in alcohol-dependent patients: summary of results from three pivotal trials.

Journal: The American journal on addictions 20080101

Title: World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Substance Use and Related Disorders, Part 1: Alcoholism.

Journal: The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20080101

Title: [Pharmacological review of alcoholic dependence treatment].

Journal: Vertex (Buenos Aires, Argentina) 20080101

Title: The efficacy of acamprosate and naltrexone in the treatment of alcohol dependence: a relative benefits analysis of randomized controlled trials.

Journal: The American journal of drug and alcohol abuse 20080101

Title: Effectiveness of sequential combined treatment in comparison with treatment as usual in preventing relapse in alcohol dependence.

Journal: Alcohol and alcoholism (Oxford, Oxfordshire) 20080101

Title: [Recent results in relaps prevention of alcoholism with Disulfiram].

Journal: Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater 20080101

Title: New therapies for alcohol dependence open options for office-based treatment.

Journal: JAMA 20071205

Title: Acamprosate attenuates cocaine- and cue-induced reinstatement of cocaine-seeking behavior in rats.

Journal: Psychopharmacology 20071201

Title: Acamprosate in the treatment of alcohol dependence: clinical and economic considerations.

Journal: Expert review of neurotherapeutics 20071101

Title: Psychometrics of the Drinker Inventory of Consequences (DrInC).

Journal: Addictive behaviors 20070801

Title: The effect of naltrexone and acamprosate on cue-induced craving, autonomic nervous system and neuroendocrine reactions to alcohol-related cues in alcoholics.

Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20070701

Title: Acamprosate and primitive reflexes.

Journal: The Annals of pharmacotherapy 20070401

Title: Measuring economic outcomes of alcohol treatment using the Economic Form 90.

Journal: Journal of studies on alcohol and drugs 20070301

Title: Emerging approaches to managing alcohol dependence.

Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20070301

Title: Improving adherence in patients with alcohol dependence: a new role for pharmacists.

Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20070301

Title: Alcohol dependence and pharmacologic treatment. Introduction.

Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20070301

Title: Schizophrenia and co-occurring substance use disorder.

Journal: The American journal of psychiatry 20070301

Title: Evidence for the role of dopamine D3 receptors in oral operant alcohol self-administration and reinstatement of alcohol-seeking behavior in mice.

Journal: Addiction biology 20070301

Title: Influence of age at drinking onset on the alcohol deprivation effect and stress-induced drinking in female rats.

Journal: Pharmacology, biochemistry, and behavior 20070201

Title: Preclinical and clinical pharmacology of alcohol dependence.

Journal: Fundamental & clinical pharmacology 20070201

Title: [Neurobiological mechanisms and pharmacological treatment options for alcohol craving].

Journal: Fortschritte der Neurologie-Psychiatrie 20070101

Title: [Pharmacological relapse prevention in alcohol and tobacco dependence].

Journal: Der Internist 20070101

Title: Glutamate-modulating drugs & the treatment of mental disorders.

Journal: Journal of psychosocial nursing and mental health services 20070101

Title: Therapeutics for alcoholism: what's the future?

Journal: Drug and alcohol review 20070101

Title: Consideration of acamprosate for treatment of amyotrophic lateral sclerosis.

Journal: Medical hypotheses 20070101

Title: Prescription procedures in medication for relapse prevention after inpatient treatment for alcohol use disorders in Switzerland.

Journal: Alcohol and alcoholism (Oxford, Oxfordshire) 20070101

Title: Results from two pharmacotherapy trials show alcoholic smokers were more severely alcohol dependent but less prone to relapse than alcoholic non-smokers.

Journal: Alcohol and alcoholism (Oxford, Oxfordshire) 20070101

Title: Treatment of tinnitus with acamprosate.

Journal: Progress in brain research 20070101

Title: Somatic configuration: a model for an integrated approach to the understanding of disease.

Journal: Substance use & misuse 20070101

Title: The application of machine learning techniques as an adjunct to clinical decision making in alcohol dependence treatment.

Journal: Substance use & misuse 20070101

Title: [Drugs against alcohol abuse].

Journal: Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20061214

Title: New pharmacological approaches for the treatment of alcoholism.

Journal: Expert opinion on pharmacotherapy 20061201

Title: Trends in the adoption of medications for alcohol dependence.

Journal: Journal of clinical psychopharmacology 20061201

Title: Substance use disorders and Schizophrenia: a question of shared glutamatergic mechanisms.

Journal: Neurotoxicity research 20061201

Title: Use of pharmacotherapies for the management of addictive behaviours in Australian clinical practice.

Journal: Addictive behaviors 20061101

Title: Evidence of a flip-flop phenomenon in acamprosate pharmacokinetics: an in vivo study in rats.

Journal: Biopharmaceutics & drug disposition 20061001

Title: Naltrexone versus acamprosate in the treatment of alcohol dependence: A multi-centre, randomized, double-blind, placebo-controlled trial.

Journal: Addiction (Abingdon, England) 20061001

Title: Choosing the right medication for the treatment of alcoholism.

Journal: Current psychiatry reports 20061001

Title: Which treatment for alcohol dependence: naltrexone, acamprosate and/or behavioural intervention?

Journal: Expert opinion on pharmacotherapy 20061001

Title: Pharmacological treatment of alcohol dependence: target symptoms and target mechanisms.

Journal: Pharmacology & therapeutics 20060901

Title: Effects of acamprosate on sleep during alcohol withdrawal: A double-blind placebo-controlled polysomnographic study in alcohol-dependent subjects.

Journal: Alcoholism, clinical and experimental research 20060901

Title: Effects of treatment with acamprosate on beta-endorphin plasma concentration in humans with high alcohol preference.

Journal: Neuroscience letters 20060814

Title: Effect of oral acamprosate on abstinence in patients with alcohol dependence in a double-blind, placebo-controlled trial: the role of patient motivation.

Journal: Journal of psychiatric research 20060801

Title: Hypothalamic-pituitary-adrenocortical axis activity: a target of pharmacological anticraving treatment?

Journal: Biological psychiatry 20060701

Title: Clinically relevant pharmacology of neuropsychiatric drugs approved over the last three years: part I.

Journal: Journal of psychiatric practice 20060701

Title: Attenuation of cocaine-induced reinstatement of cocaine conditioned place preference by acamprosate.

Journal: Behavioural pharmacology 20060601

Title: [Maintaining abstinence after alcohol detoxification].

Journal: La Revue du praticien 20060531

Title: Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.

Journal: JAMA 20060503

Title: What's new in clinical pharmacology and therapeutics.

Journal: WMJ : official publication of the State Medical Society of Wisconsin 20060501

Title: Pharmacotherapy for alcohol dependence: anticraving medications for relapse prevention.

Journal: Yonsei medical journal 20060430

Title: A pilot study of oxcarbazepine versus acamprosate in alcohol-dependent patients.

Journal: Alcoholism, clinical and experimental research 20060401

Title: Tinnitus. Overcoming the noise.

Journal: Mayo Clinic health letter (English ed.) 20060401

Title: The BRENDA model: integrating psychosocial treatment and pharmacotherapy for the treatment of alcohol use disorders.

Journal: Journal of psychiatric practice 20060301

Title: Schedule-induced alcohol drinking: non-selective effects of acamprosate and naltrexone.

Journal: Addiction biology 20060301

Title: N-methyl-D-aspartate and group I metabotropic glutamate receptors are involved in the expression of ethanol-induced sensitization in mice.

Journal: Behavioural pharmacology 20060201

Title: New drugs 06, part I.

Journal: Nursing 20060201

Title: Alcoholism and suicidal behavior: a clinical overview.

Journal: Acta psychiatrica Scandinavica 20060101

Title: Combined acamprosate and naltrexone, with cognitive behavioural therapy is superior to either medication alone for alcohol abstinence: a single centres' experience with pharmacotherapy.

Journal: Alcohol and alcoholism (Oxford, Oxfordshire) 20060101

Title: Extended-release intramuscular naltrexone: a viewpoint by Henry R Kranzler.

Journal: Drugs 20060101

Title: Is acamprosate use in alcohol dependence treatment reflected in improved subjective health status outcomes beyond cognitive behavioural therapy alone?

Journal: Journal of addictive diseases 20060101

Title: Can experimental paradigms and animal models be used to discover clinically effective medications for alcoholism?

Journal: Addiction biology 20051201

Title: New alcohol abuse drugs emerging. Anti-craving meds are finally here to treat alcohol dependence, recognized as a disease of the brain.

Journal: Health news (Waltham, Mass.) 20051201

Title: Changes in the beta-endorphin plasma level after repeated treatment with acamprosate in rats selectively bred for high and low alcohol preference.

Journal: Neuroscience letters 20051104

Title: Medications for treating alcohol dependence.

Journal: American family physician 20051101

Title: The efficacy of compliance therapy in pharmacotherapy for alcohol dependence: a randomized controlled trial.

Journal: Journal of studies on alcohol 20051101

Title: Acamprosate in the treatment of alcohol dependence.

Journal: Expert opinion on pharmacotherapy 20051001

Title: Production of reactive oxygen species following acute ethanol or acetaldehyde and its reduction by acamprosate in chronically alcoholized rats.

Journal: European journal of pharmacology 20050927

Title: Increasing leptin precedes craving and relapse during pharmacological abstinence maintenance treatment of alcoholism.

Journal: Journal of psychiatric research 20050901

Title: The acute anti-craving effect of acamprosate in alcohol-preferring rats is associated with modulation of the mesolimbic dopamine system.

Journal: Addiction biology 20050901

Title: Acamprosate.

Journal: Nursing times 20050901

Title: Challenges and opportunities for medications development in alcoholism: an international perspective on collaborations between academia and industry.

Journal: Alcoholism, clinical and experimental research 20050801

Title: A neuroendocrinological hypothesis on gender effects of naltrexone in relapse prevention treatment.

Journal: Pharmacopsychiatry 20050701

Title: Drug treatment for alcoholism today.

Journal: The Harvard mental health letter 20050701

Title: Combining treatments for alcoholism: why and how?

Journal: Journal of studies on alcohol. Supplement 20050701

Title: COMBINE genetics study: the pharmacogenetics of alcoholism treatment response: genes and mechanisms.

Journal: Journal of studies on alcohol. Supplement 20050701

Title: Choosing pharmacotherapies for the COMBINE Study--process and procedures: an investigational approach to combination pharmacotherapy for the treatment of alcohol dependence.

Journal: Journal of studies on alcohol. Supplement 20050701

Title: Rationale for combining acamprosate and naltrexone for treating alcohol dependence.

Journal: Journal of studies on alcohol. Supplement 20050701

Title: The COMBINE SAFTEE: a structured instrument for collecting adverse events adapted for clinical studies in the alcoholism field.

Journal: Journal of studies on alcohol. Supplement 20050701

Title: The effects of acamprosate and neramexane on cue-induced reinstatement of ethanol-seeking behavior in rat.

Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20050601

Title: Acamprosate for the treatment of alcohol dependence.

Journal: Clinical therapeutics 20050601

Title: Repeated-testing of place preference expression for evaluation of anti-craving-drug effects.

Journal: Amino acids 20050501

Title: New drug released for alcohol dependency.

Journal: Mayo Clinic health letter (English ed.) 20050401

Title: Acamprosate (Campral) for alcoholism.

Journal: Connecticut medicine 20050401

Title: Predictors of acamprosate efficacy: results from a pooled analysis of seven European trials including 1485 alcohol-dependent patients.

Journal: Psychopharmacology 20050301

Title: Effect of acamprosate on neonatal excitotoxic cortical lesions in in utero alcohol-exposed hamsters.

Journal: Neuroscience letters 20050210

Title: Anti-craving drugs acamprosate and naloxone do not reduce expression of morphine conditioned place preference in isolated and group-housed rats.

Journal: Neuroscience letters 20050210

Title: Acamprosate campral for alcoholism.

Journal: The Medical letter on drugs and therapeutics 20050103

Title: Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats.

Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20050101

Title: The clock gene Per2 influences the glutamatergic system and modulates alcohol consumption.

Journal: Nature medicine 20050101

Title: New drugs: acamprosate calcium and solifenacin succinate.

Journal: Journal of the American Pharmacists Association : JAPhA 20050101

Title: Pharmacological relapse prevention of alcoholism: clinical predictors of outcome.

Journal: European addiction research 20050101

Title: Effect of the combined administration of ethanol and acamprosate on rabbit EEG.

Journal: Pharmacological reports : PR 20050101

Title: Effect of community nurse follow-up when treating alcohol dependence with acamprosate.

Journal: Alcohol and alcoholism (Oxford, Oxfordshire) 20050101

Title: Acamprosate: a review of its use in the maintenance of abstinence in patients with alcohol dependence.

Journal: CNS drugs 20050101

Title: A critical review of pharmacoeconomic studies of acamprosate.

Journal: Alcohol and alcoholism (Oxford, Oxfordshire) 20050101

Title: Neuroprotective and abstinence-promoting effects of acamprosate: elucidating the mechanism of action.

Journal: CNS drugs 20050101

Title: An open randomized study comparing disulfiram and acamprosate in the treatment of alcohol dependence.

Journal: Alcohol and alcoholism (Oxford, Oxfordshire) 20050101

Title: Clinical characterization of use of acamprosate and naltrexone: data from an addiction center in India.

Journal: The American journal on addictions 20050101

Title: Pharmacotherapy of alcohol use disorders.

Journal: Substance use & misuse 20050101

Title: Tinnitus treatment with acamprosate: double-blind study.

Journal: Brazilian journal of otorhinolaryngology 20050101

Title: Pharmacotherapy, pharmacogenomics, and the future of alcohol dependence treatment, part 1.

Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20041101

Title: Effect of neramexane on ethanol dependence and reinforcement.

Journal: European journal of pharmacology 20041025

Title: Recent advances in the pharmacotherapy of alcoholism.

Journal: Current psychiatry reports 20041001

Title: The mosaic of addiction.

Journal: The American journal of psychiatry 20041001

Title: Ask the doctor. I need to quit drinking, but don't think I can do it on my own. Can I use a drug like Antabuse even though I have heart disease?

Journal: Harvard heart letter : from Harvard Medical School 20041001

Title: Assessment and modulation of acamprosate intestinal absorption: comparative studies using in situ, in vitro (CACO-2 cell monolayers) and in vivo models.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20040801

Title: Biphasic effect of acamprosate on NMDA but not on GABAA receptors in spontaneous rhythmic activity from the isolated neonatal rat respiratory network.

Journal: Neuropharmacology 20040701

Title: Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review.

Journal: Addiction (Abingdon, England) 20040701

Title: Synthesis and assessment of [11C]acetylhomotaurine as an imaging agent for the study of the pharmacodynamic properties of acamprosate by positron emission tomography.

Journal: Nuclear medicine and biology 20040701

Title: The NMDA receptor channel blocker memantine and opioid receptor antagonist naltrexone inhibit the saccharin deprivation effect in rats.

Journal: Behavioural pharmacology 20040701

Title: Alcohol effects during acamprosate treatment: a dose-response study in humans.

Journal: Alcoholism, clinical and experimental research 20040701

Title: Hypothalamic-pituitary-adrenal system regulation in recently detoxified alcoholics is not altered by one week of treatment with acamprosate.

Journal: Pharmacopsychiatry 20040501

Title: [The pharmacologic treatment of the alcohol dependence].

Journal: Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) 20040501

Title: Effect of the combination of naltrexone and acamprosate on alcohol intake in mice.

Journal: Psychiatry and clinical neurosciences 20040201

Title: NR2B subunit selective NMDA antagonists inhibit neurotoxic effect of alcohol-withdrawal in primary cultures of rat cortical neurones.

Journal: Neurochemistry international 20040101

Title: The efficacy of acamprosate in the maintenance of abstinence in alcohol-dependent individuals: results of a meta-analysis.

Journal: Alcoholism, clinical and experimental research 20040101

Title: Improvement in quality of life after treatment for alcohol dependence with acamprosate and psychosocial support.

Journal: Alcoholism, clinical and experimental research 20040101

Title: Acamprosate in alcohol dependence: a randomized controlled efficacy study in a standard clinical setting.

Journal: Journal of studies on alcohol 20040101

Title: A comparison of two intensities of psychosocial intervention for alcohol dependent patients treated with acamprosate.

Journal: Alcohol and alcoholism (Oxford, Oxfordshire) 20040101

Title: Pharmacodynamic effects of acamprosate on markers of cerebral function in alcohol-dependent subjects administered as pretreatment and during alcohol abstinence.

Journal: Neuropsychobiology 20040101

Title: A pragmatic trial of acamprosate in the treatment of alcohol dependence in primary care.

Journal: Alcohol and alcoholism (Oxford, Oxfordshire) 20040101

Title: Combined therapy: what does acamprosate and naltrexone combination tell us?

Journal: Alcohol and alcoholism (Oxford, Oxfordshire) 20040101

Title: Pragmatic trials and the ARES study.

Journal: Alcohol and alcoholism (Oxford, Oxfordshire) 20040101

Title: New drug to treat alcoholism.

Journal: FDA consumer 20040101

Title: Acamprosate involvement in triacylglycerol hydrolysis and transacylation with cholesterol in chronically ethanol-drinking rats.

Journal: Journal of basic and clinical physiology and pharmacology 20040101

Title: Acamprosate and naltrexone treatment for alcohol dependence: an evidence-based risk-benefits assessment.

Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20031201

Title: Does acamprosate improve reduction of drinking as well as aiding abstinence?

Journal: Journal of psychopharmacology (Oxford, England) 20031201

Title: [Acamprosate--new preclinical research aspects].

Journal: MMW Fortschritte der Medizin 20031009

Title: [Advances in the treatment of alcohol dependence: pharmacological relapse prevention].

Journal: MMW Fortschritte der Medizin 20031009

Title: Acamprosate blocks the increase in dopamine extracellular levels in nucleus accumbens evoked by chemical stimulation of the ventral hippocampus.

Journal: Naunyn-Schmiedeberg's archives of pharmacology 20031001

Title: [Psychosocial treatment plus drug prophylaxis. Fewer recurrences after alcohol withdrawal].

Journal: MMW Fortschritte der Medizin 20030904

Title: Efficacy of acamprosate in the treatment of alcohol-dependent outpatients.

Journal: Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) 20030901

Title: New pharmacotherapies for alcohol dependence: are they being used and what do they cost?

Journal: The Medical journal of Australia 20030818

Title: Effects of naltrexone alone and in combination with acamprosate on the alcohol deprivation effect in rats.

Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20030801

Title: The effect of acamprosate on the development of morphine-induced behavioral sensitization in rats.

Journal: Behavioural pharmacology 20030701

Title: Testing combined pharmacotherapies and behavioral interventions in alcohol dependence: rationale and methods.

Journal: Alcoholism, clinical and experimental research 20030701

Title: Testing combined pharmacotherapies and behavioral interventions for alcohol dependence (the COMBINE study): a pilot feasibility study.

Journal: Alcoholism, clinical and experimental research 20030701

Title: Acamprosate and its efficacy in treating alcohol dependent adolescents.

Journal: European child & adolescent psychiatry 20030601

Title: Acamprosate does not induce a conditioned place preference and reveals no state-dependent effects in this paradigm.

Journal: Progress in neuro-psychopharmacology & biological psychiatry 20030601

Title: Dose-ranging kinetics and behavioral pharmacology of naltrexone and acamprosate, both alone and combined, in alcohol-dependent subjects.

Journal: Journal of clinical psychopharmacology 20030601

Title: A pilot study on the effects of treatment with acamprosate on craving for alcohol in alcohol-dependent patients.

Journal: Addiction biology 20030601

Title: [Preventing recurrence after alcohol withdrawal treatment with drugs. Reducing the drive to drink].

Journal: MMW Fortschritte der Medizin 20030508

Title: Physicians' opinions about medications to treat alcoholism.

Journal: Addiction (Abingdon, England) 20030501

Title: Cost-effectiveness of adjuvant treatment with acamprosate in maintaining abstinence in alcohol dependent patients.

Journal: European addiction research 20030401

Title: Effects of acamprosate on excitatory amino acids during multiple ethanol withdrawal periods.

Journal: Alcoholism, clinical and experimental research 20030301

Title: Local acamprosate modulates dopamine release in the rat nucleus accumbens through NMDA receptors: an in vivo microdialysis study.

Journal: Naunyn-Schmiedeberg's archives of pharmacology 20030201

Title: [Deficits in preventing recurrence in alcoholic patients. Withdrawal--and immediately back to the bottle].

Journal: MMW Fortschritte der Medizin 20030116

Title: Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism: a double-blind, placebo-controlled study.

Journal: Archives of general psychiatry 20030101

Title: The anti-relapse compound acamprosate inhibits the development of a conditioned place preference to ethanol and cocaine but not morphine.

Journal: British journal of pharmacology 20030101

Title: Acamprosate in Korean alcohol-dependent patients: a multi-centre, randomized, double-blind, placebo-controlled study.

Journal: Alcohol and alcoholism (Oxford, Oxfordshire) 20030101

Title: Acamprosate.

Journal: Recent developments in alcoholism : an official publication of the American Medical Society on Alcoholism, the Research Society on Alcoholism, and the National Council on Alcoholism 20030101

Title: Acamprosate for the adjunctive treatment of alcohol dependence.

Journal: The Annals of pharmacotherapy 20030101

Title: Research advances in the understanding and treatment of addiction.

Journal: The American journal on addictions 20030101

Title: The anti-craving taurine derivative acamprosate: failure to extinguish morphine conditioned place preference.

Journal: Advances in experimental medicine and biology 20030101

Title: Pharmacology of acamprosate: an overview.

Journal: CNS drug reviews 20030101

Title: [Acamprosate (Aotal): could adverse effects upset the treatment of alcohol dependence?].

Journal: Therapie 20030101

Title: [Neural basis of alcohol dependence].

Journal: Duodecim; laaketieteellinen aikakauskirja 20030101

Title: [Drug therapy of alcohol dependence--a critical review].

Journal: Duodecim; laaketieteellinen aikakauskirja 20030101

Title: Pharmacological mechanisms of naltrexone and acamprosate in the prevention of relapse in alcohol dependence.

Journal: The American journal on addictions 20030101

Title: Current pharmacotherapies of alcoholism: a U.S. perspective.

Journal: The American journal on addictions 20030101

Title: Use of acamprosate and opioid antagonists in the treatment of alcohol dependence: a European perspective.

Journal: The American journal on addictions 20030101

Title: Acamprosate inhibits the binding and neurotoxic effects of trans-ACPD, suggesting a novel site of action at metabotropic glutamate receptors.

Journal: Alcoholism, clinical and experimental research 20021201

Title: Cognitive behavioural therapy combined with the relapse-prevention medication acamprosate: are short-term treatment outcomes for alcohol dependence improved?

Journal: The Australian and New Zealand journal of psychiatry 20021001

Title: Disposition of acamprosate in the rat: influence of probenecid.

Journal: Biopharmaceutics & drug disposition 20021001

Title: Acamprosate reduces context-dependent ethanol effects.

Journal: Psychopharmacology 20021001

Title: A pharmacokinetic and pharmacodynamic drug interaction study of acamprosate and naltrexone.

Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20021001

Title: Acamprosate, MK-801, and ifenprodil inhibit neurotoxicity and calcium entry induced by ethanol withdrawal in organotypic slice cultures from neonatal rat hippocampus.

Journal: Alcoholism, clinical and experimental research 20021001

Title: The European NEAT program: an integrated approach using acamprosate and psychosocial support for the prevention of relapse in alcohol-dependent patients with a statistical modeling of therapy success prediction.

Journal: Alcoholism, clinical and experimental research 20021001

Title: New pharmacotherapies for alcohol dependence.

Journal: The Medical journal of Australia 20020715

Title: Acamprosate decreases the induction of tolerance and physical dependence in morphine-treated mice.

Journal: European journal of pharmacology 20020607

Title: Effects of acamprosate and some polyamine site ligands of NMDA receptor on short-term memory in rats.

Journal: European journal of pharmacology 20020524

Title: Acamprosate has no effect on NMDA-induced toxicity but reduces toxicity induced by spermidine or by changing the medium in organotypic hippocampal slice cultures from rat.

Journal: Alcoholism, clinical and experimental research 20020501

Title: [Long-term treatment of alcohol dependance].

Journal: Gastroenterologie clinique et biologique 20020501

Title: [Acamprosate and psychosocial intervention. An integrative treatment approach for prevention of alcohol dependent patients in Switzerland].

Journal: Praxis 20020424

Title: Drug treatments for alcoholism.

Journal: The Harvard mental health letter 20020401

Title: Potential neuroprotective effects of acamprosate.

Journal: Alcoholism, clinical and experimental research 20020401

Title: Effects of acute acamprosate and homotaurine on ethanol intake and ethanol-stimulated mesolimbic dopamine release.

Journal: European journal of pharmacology 20020215

Title: Central nervous system mechanisms in alcohol relapse.

Journal: Alcoholism, clinical and experimental research 20020201

Title: Long-lasting increase in voluntary ethanol consumption and transcriptional regulation in the rat brain after intermittent exposure to alcohol.

Journal: FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20020101

Title: Use of acamprosate and different kinds of psychosocial support in relapse prevention of alcoholism. Results from a non-blind, multicentre study.

Journal: Drugs in R&D 20020101

Title: Acamprosate.

Journal: Drugs in R&D 20020101

Title: Does psychosocial treatment enhance the efficacy of acamprosate in patients with alcohol problems?

Journal: Alcohol and alcoholism (Oxford, Oxfordshire) 20020101

Title: Interactions between taurine and ethanol in the central nervous system.

Journal: Amino acids 20020101

Title: Addiction medicine for the primary care physician.

Journal: The Journal of the Oklahoma State Medical Association 20011101

Title: Effects of acamprosate on sensitization to the locomotor-stimulant effects of alcohol in mice selectively bred for high and low alcohol preference.

Journal: Behavioural pharmacology 20011101

Title: Acamprosate is neuroprotective against glutamate-induced excitotoxicity when enhanced by ethanol withdrawal in neocortical cultures of fetal rat brain.

Journal: Alcoholism, clinical and experimental research 20010901

Title: Efficacy of naltrexone and acamprosate for alcoholism treatment: a meta-analysis.

Journal: Alcoholism, clinical and experimental research 20010901

Title: [Adjuvant drug treatment of alcoholism with acamprosate: between sectoral budgets and disease management].

Journal: Deutsche medizinische Wochenschrift (1946) 20010817

Title: Does the alcoholic's remedy come in a pill?

Journal: Behavioral healthcare tomorrow 20010801

Title: Combined behavioral and pharmacologic treatments of alcoholism.

Journal: American clinical laboratory 20010701

Title: The anti-craving compound acamprosate acts as a weak NMDA-receptor antagonist, but modulates NMDA-receptor subunit expression similar to memantine and MK-801.

Journal: Neuropharmacology 20010501

Title: Pharmacological relapse prevention in alcohol dependence: from animal models to clinical trials.

Journal: Alcoholism, clinical and experimental research 20010501

Title: Mechanisms of alcohol-nicotine interactions: alcoholics versus smokers.

Journal: Alcoholism, clinical and experimental research 20010501

Title: Naltrexone and acamprosate. Using new drugs for alcohol dependence.

Journal: Australian family physician 20010501

Title: Effects of acamprosate on ethanol-seeking and self-administration in the rat.

Journal: Alcoholism, clinical and experimental research 20010301

Title: Can this pill stop you from hitting the bottle?

Journal: Newsweek 20010212

Title: Effect of acamprosate and naltrexone, alone or in combination, on ethanol consumption.

Journal: Alcohol (Fayetteville, N.Y.) 20010201

Title: The European acamprosate trials: conclusions for research and therapy.

Journal: Journal of biomedical science 20010101

Title: Neurotoxic effect of acamprosate, n-acetyl-homotaurine, in cultured neurons.

Journal: Journal of biomedical science 20010101

Title: New developments in the pharmacotherapy of alcohol dependence.

Journal: The American journal on addictions 20010101

Title: Acamprosate during and after acute alcohol withdrawal: a double-blind placebo-controlled study in Spain.

Journal: Alcohol and alcoholism (Oxford, Oxfordshire) 20010101

Title: Naltrexone versus acamprosate: one year follow-up of alcohol dependence treatment.

Journal: Alcohol and alcoholism (Oxford, Oxfordshire) 20010101

Title: Pharmacologic approaches to the management of alcoholism.

Journal: The Journal of clinical psychiatry 20010101

Title: Treatment of alcohol-dependent outpatients with acamprosate: a clinical review.

Journal: The Journal of clinical psychiatry 20010101

Title: Effects of acamprosate and scopolamine on the working memory of rats in a three-panel runway task.

Journal: Journal of basic and clinical physiology and pharmacology 20010101

Title: [The neuroprotective effect of the glutamate antagonist acamprosate following experimental cerebral ischemia. A study with the lipid peroxidase inhibitor u-101033e].

Journal: Der Anaesthesist 20000901

Title: Acamprosate. A review of its pharmacology and clinical potential in the management of alcohol dependence after detoxification.

Journal: Drugs 19970601

Title: Ability of calcium bis acetyl homotaurine, a GABA agonist, to prevent relapse in weaned alcoholics.

Journal: Lancet (London, England) 19850504

Title: Preuss UW.Commentary on the study: impact of depressive symptoms on future alcohol use in patients with co-occurring bipolar disorder and alcohol dependence: a prospective analysis in an 8-week randomized controlled trial of acamprosate (Prisciandaro et al.).Alcohol Clin Exp Res. 2012 Jun;36(6):967-9. doi: 10.1111/j.1530-0277.2012.01827.x.

Title: Witkiewitz K, Saville K, Hamreus K.Acamprosate for treatment of alcohol dependence: mechanisms, efficacy, and clinical utility.Ther Clin Risk Manag. 2012;8:45-53.

Title: Gahr M, et al.Relapse prevention in alcohol dependence: acamprosate and naltrexone as a combined pharmacological strategy.Nervenarzt. 2012 Aug 15.

Title: Palucha-Poniewiera A, Pilc A.Involvement of mGlu5 and NMDA receptors in the antidepressant-like effect of acamprosate in the tail suspension test.Prog Neuropsychopharmacol Biol Psychiatry. 2012 Oct 1;39(1):102-6.

Title: Hinton DJ, et al.Ethanol withdrawal-induced brain metabolites and the pharmacological effects of acamprosate in mice lacking ENT1.Neuropharmacology. 2012 Jun;62(8):2480-8.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 77337-73-6
Tags:77337-73-6 Molecular Formula|77337-73-6 MDL|77337-73-6 SMILES|77337-73-6 Acamprosate Calcium